Coherus Oncology Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Coherus Oncology, Inc. (CHRS) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Operating Activities
Net Income28.51-237.89-291.75-287.10132.2489.83-209.41
Depreciation & Amortization5.283.799.403.452.895.473.24
Stock Based Compensation27.8043.1150.7451.3638.160.000.00
Change in Working Capital55.89-36.83-55.2942.36-34.65-173.0710.30
Change in Accounts Receivable149.35-150.6813.0534.06-15.220.000.00
Change in Inventory-31.95-46.73-47.35-6.25-38.360.000.00
Change in Accounts Payable-3.9423.76-4.550.87-9.820.000.00
Change in Other Working Capital-57.57136.838.2313.6828.750.000.00
Other Operating Activities-137.9250.5390.30143.9312.02110.03-1.75
Net Cash from Operating Activities-20.44-174.88-241.12-37.43154.1528.36-159.27
Investing Activities
Capital Expenditures0.00-0.292.04-1.29-7.231.82-0.79
Acquisitions0.007.00-35.000.000.000.04-0.70
Purchases of Investments0.00138.14-127.38-1.120.160.000.00
Sales/Maturities of Investments14.89157.64-164.81-137.12-7.50-10.910.30
Other Investing Activities215.43-0.49-37.43-136.00-7.50-11.080.00
Net Cash from Investing Activities230.32144.64-166.85-138.41-14.40-12.73-1.19
Financing Activities
Debt Repayment-223.410.00-190.75-0.67-0.390.000.00
Common Stock Issued1.4674.222.3254.3021.233.52101.75
Common Stock Repurchased0.00-3.59-3.74-1.75-0.880.000.00
Other Financing Activities34.98-1.03-4.97-0.67-18.567.340.00
Net Cash from Financing Activities-186.9769.6054.3351.88223.9589.37105.42
Summary
Effect of Forex Changes on Cash0.000.000.000.000.00-0.280.47
Net Change in Cash22.9139.36-353.65-123.96363.69104.72-55.03
Cash at Beginning of Period103.3463.99417.64541.60177.9173.19127.76
Cash at End of Period126.25103.3463.99417.64541.60177.9173.19
Free Cash Flow-20.44-174.88-243.16-38.72146.9126.53-160.06
Supplemental Disclosures
Interest Paid25.3837.8634.8818.6816.9615.268.20
Income Taxes Paid-0.11-0.120.041.223.951.730.00